An interventional study of Oral water intake in Pregnancy and Gestational Diabetes Mellitus (GDM), sponsored by Ankara City Hospital Bilkent. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-10-15.
Sponsored by Ankara City Hospital Bilkent · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 52 studies in Diabetes, Gestational with a site in Turkey — 9 open to participants now, 12 under way, none of them phase 3. Diabetes, Gestational · Turkey.
Among the 52 studies in Diabetes, Gestational with a site in Turkey, this one is the 11th largest by enrollment of the 28 interventional ones that give a count, is one of 7 that started in 2025, is one of 28 with no phase, and was the 47th registered.
878 studies on the registry are indexed under Diabetes, Gestational; 196 are open to participants now.
Browse Diabetes, Gestational studies →9 of the 52 studies in Diabetes, Gestational with a site in Turkey are open now. Recruiting first, the newest first:
Burak Deniz Aydoğdu · Sites in Turkey
Ages 18–50 · Women only
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization · Sites in Turkey
Ages 18–50 · Women only · Healthy volunteers
Izmir Ataturk Training and Research Hospital · Sites in Turkey
Ages 18–45 · Women only · Healthy volunteers
Izmir Katip Celebi University · Sites in Turkey
Ages 18+ · Women only
Umraniye Education and Research Hospital · Sites in Turkey
Ages 18–39 · Women only
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 132 Diabetes, Gestational studies recruiting now, 60 (45%) set no upper age limit and 70 (53%) stop at 75 or younger; 12 take children under 18; 60 take healthy volunteers.
This study: 18 Years to 40 Years · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
52 studies; the count open now beside each. This study's row is marked.
First in 2013; this study’s year is marked. 7 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 95 is below the median of 110 across 563 interventional studies indexed under Diabetes, Gestational.
Median enrollment 85 across the 28 interventional studies, 100 across the 24 observational. Of the 37 that completed or were terminated, 2 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 52 has an industry lead sponsor. The 10 most frequent:
Ankara City Hospital Bilkent is the lead sponsor of 450 studies on the registry; 110 are open to participants now.
Ankara City Hospital Bilkent has 3 studies filed under Diabetes, Gestational — fewer than ten, so there is no comparison to draw.
2 of the studies in Diabetes, Gestational with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07750431Samsun UniversityThe Role of Progesterone Membrane Receptors in the Development of Gestational Diabetes Mellitus | 2027-01-01 |
| NCT07067411Yeditepe UniversityGamified Education for Diabetes Self-Management in GDM | 2027-07-01 |
Add all 2 to your calendar (.ics) → With an account.
Among the 52 studies in Diabetes, Gestational with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Pulmonary aspiration of gastric contents during anesthesia is a serious perioperative complication associated with significant morbidity and mortality. Pregnant women are at increased risk of aspiration because of physiological changes such as delayed gastric emptying and increased intra-abdominal pressure. In addition, gestational diabetes mellitus (GDM) may affect gastric motility and gastric emptying.
Current fasting guidelines allow the intake of clear fluids up to two hours before anesthesia. However, the effect of preoperative oral clear fluid intake on gastric volume in pregnant women with GDM remains unclear.
This prospective interventional study compares gastric volume measured by gastric ultrasonography in term pregnant women with and without gestational diabetes mellitus (GDM) undergoing elective cesarean delivery. Participants receive 200 mL of oral water after baseline gastric ultrasonography. Gastric ultrasonography is performed before water intake (T1), immediately after completion of water intake (T2), and two hours after water intake immediately before anesthesia (T3) to evaluate gastric volume and gastric content.
The study aims to improve the assessment of gastric volume and perioperative fasting in pregnant women, particularly those with gestational diabetes mellitus.
Pulmonary aspiration of gastric contents is one of the most feared complications of obstetric anesthesia and may lead to significant morbidity and mortality. Pregnancy is associated with physiological changes including increased intra-abdominal pressure, gastroesophageal reflux, and alterations in gastric emptying, which may increase perioperative aspiration risk. Gestational diabetes mellitus (GDM) may further affect gastric motility and gastric emptying.
Preoperative fasting guidelines from major anesthesia societies allow the intake of clear fluids up to two hours before anesthesia. However, the effect of preoperative oral clear fluid intake on gastric volume in pregnant women with gestational diabetes mellitus remains unclear.
This single-center prospective interventional study evaluates term pregnant women scheduled for elective cesarean delivery. Participants are included in two groups according to the presence or absence of gestational diabetes mellitus. The GDM group includes women with gestational diabetes mellitus managed with diet or insulin during pregnancy, while the control group includes pregnant women without GDM.
After standard preoperative fasting, baseline gastric ultrasonography is performed immediately before oral fluid intake (T1). Participants then consume 200 mL of room-temperature drinking water orally. Gastric ultrasonography is repeated immediately after completion of water intake (T2) and two hours after water intake, immediately before anesthesia (T3).
Gastric ultrasonography is performed in the semi-recumbent and right lateral decubitus positions. The gastric antrum is identified using anatomical landmarks including the left lobe of the liver, pancreas, aorta, and inferior vena cava. The gastric antral cross-sectional area is calculated using the formula CSA = (D1 × D2 × π) / 4.
Gastric volume is estimated using the Roukhomovsky equation. Gastric contents are also qualitatively assessed using the three-grade Perlas grading system (Grade 0, 1, or 2).
Gastric volume is standardized to body weight in mL/kg. A standardized gastric volume greater than 1.5 mL/kg is classified as exceeding the high gastric volume threshold. This threshold is used as an ultrasonographic indicator of high gastric volume rather than as a direct threshold for pulmonary aspiration.
The primary objective is to compare the pattern of gastric volume change across the three predefined time points between pregnant women with GDM and those without GDM. Secondary assessments include qualitative evaluation of gastric contents using the Perlas grading system and the proportion of participants exceeding the high gastric volume threshold.
The criteria were revised on the registry on Oct 7, 2026. See what changed
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Term pregnant women with gestational diabetes mellitus managed with diet or insulin during pregnancy. Participants receive 200 mL of oral water after baseline gastric ultrasonography and undergo gastric ultrasonography at three predefined time points: before water intake (T1), immediately after water intake (T2), and 2 hours after water intake (T3).
Other: Oral water intake
Term pregnant women without gestational diabetes mellitus. Participants receive 200 mL of oral water after baseline gastric ultrasonography and undergo gastric ultrasonography at three predefined time points: before water intake (T1), immediately after water intake (T2), and 2 hours after water intake (T3).
Other: Oral water intake
Participants consume 200 mL of room-temperature drinking water orally immediately after the baseline gastric ultrasonography assessment (T1). Gastric ultrasonography is then repeated immediately after completion of water intake (T2) and 2 hours after water intake (T3).
Gastric Volume Across Three Time Points
Gastric volume (mL) will be calculated from gastric antral cross-sectional area measurements obtained by ultrasonography using the Roukhomovsky equation. Gastric volume will be assessed at three predefined time points in women with gestational diabetes mellitus and women without gestational diabetes mellitus. The primary outcome is the difference in the pattern of gastric volume change over time between the two groups.
Time frame: T1: after standard preoperative fasting, immediately before intake of 200 mL water; T2: immediately after completion of 200 mL water intake; T3: 2 hours after water intake, immediately before anesthesia.
Qualitative Assessment of Gastric Contents Using the Perlas Grading System
Gastric contents will be qualitatively assessed using the three-grade Perlas grading system (Grade 0, 1, or 2) based on ultrasonographic examination in the semi-recumbent and right lateral decubitus positions. The distribution of Perlas grades will be compared between groups and across the three measurement time points.
Time frame: T1: before 200 mL water intake; T2: immediately after 200 mL water intake; T3: 2 hours after water intake.
Proportion of Participants Exceeding the High Gastric Volume Threshold (>1.5 mL/kg)
Gastric volume will be standardized to body weight (mL/kg). A standardized gastric volume \>1.5 mL/kg will be classified as exceeding the high gastric volume threshold. This threshold is used as an ultrasonographic classification of high-volume gastric contents and is not considered a direct threshold for pulmonary aspiration. The proportion of participants exceeding this threshold will be compared between groups and across time points.
Time frame: T1: before 200 mL water intake; T2: immediately after 200 mL water intake; T3: 2 hours after water intake.
Plan to share: No
No publications or documents are linked to this record.
Ran from Dec 2025 to primary completion in Jul 2026, 7 months.
Of 306 non-industry interventional studies with no phase under Diabetes, Gestational, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 48. This study's 7 months is below that.
Counting every sponsor, half of 309 studies reached it within 28 months; a quarter within 13 and three quarters within 48.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ankara City Hospital Bilkent →